Guselkumab Shows Similar Domain-Specific Efficacy in Females and Males with Active Psoriatic Arthritis: Post Hoc Analyses of Three Phase 3, Randomized, Double-blind, Placebo-Controlled Studies

被引：0

作者：

Eder, Lihi ^{[1
,2
]}

Selmi, Carlo ^{[3
]}

Mease, Philip ^{[4
,5
]}

Ogdie, Alexis ^{[6
]}

Nantel, Francois ^{[7
]}

Lavie, Frederic ^{[8
]}

Sharaf, Mohamed ^{[9
]}

Adelakun, Oyediran ^{[10
]}

Rampakakis, Emmanouil ^{[11
]}

Vegas, Laura Pina ^{[12
]}

Coates, Laura ^{[13
]}

机构：

[1] Univ Toronto, Womens Coll Hosp, Toronto, ON, Canada

[2] Dept Med, Toronto, ON, Canada

[3] IRCCS Ist Clin Humanitas, Rozzano, Italy

[4] Providence St Joseph, Swedish Med Ctr, Seattle, WA USA

[5] Univ Washington, Sch Med, Seattle, WA USA

[6] Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA USA

[7] Nantel MedSci Consult, Montreal, PQ, Canada

[8] Janssen Cilag Global Med Affairs, Immunol Global Med Affairs, Issy Les Moulineaux, France

[9] Middle East FZ LLC, Johnson & Johnson, Dubai, U Arab Emirates

[10] Janssen Res Dev LLC, Titusville, NJ USA

[11] McGill Univ, Dept Pediat Sci Affairs, JSS Med Res Inc, Montreal, PQ, Canada

[12] Leiden Univ, Med Ctr, Leiden, Netherlands

[13] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England

来源：

ARTHRITIS & RHEUMATOLOGY | 2024年 / 76卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

2342

引用

页码：4720 / 4722

页数：3

共 50 条

[41] Alefacept in combination with methotrexate for treatment of active psoriatic arthritis: Rationale and design of a randomized, double-blind, placebo-controlled study
Gladman, D
Keystone, E
Gottlieb, A
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 50 (03) : P60 - P60
[42] Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis - Results of a double-blind, randomized, placebo-controlled trial
Mease, PJ
Gladman, DD
Ritchlin, CT
Ruderman, EM
Steinfeld, SD
Choy, EHS
Sharp, JT
Ory, PA
Perdok, RJ
Weinberg, MA
ARTHRITIS AND RHEUMATISM, 2005, 52 (10): : 3279 - 3289
[43] Efficacy and safety of leflunomide in the treatment of psoriatic arthritis and psoriasis - A multinational, double-blind, randomized, placebo-controlled clinical trial
Kaltwasser, JP
Nash, P
Gladman, D
Rosen, CF
Behrens, F
Jones, P
Wollenhaupt, J
Falk, FG
Mease, P
ARTHRITIS AND RHEUMATISM, 2004, 50 (06): : 1939 - 1950
[44] EFFICACY AND SAFETY RESULTS OF GUSELKUMAB, AN ANTI-IL23 MONOCLONAL ANTIBODY, IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS OVER 24 WEEKS: A PHASE 2A, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
Deodhar, A.
Gottlieb, A.
Boehncke, W. -H.
Dong, B.
Wang, Y.
Barchuk, W.
Xu, X. L.
Hsia, E.
ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 142 - 143
[45] Efficacy and Safety Results of Guselkumab, an Anti-IL23 Monoclonal Antibody, in Patients with Active Psoriatic Arthritis over 24 Weeks: A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Study
Deodhar, Atul A.
Gottlieb, Alice B.
Boehncke, Wolf-Henning
Dong, Bin
Wang, Yuhua
Barchuk, William
Xu, Xie
Hsia, Elizabeth C.
ARTHRITIS & RHEUMATOLOGY, 2016, 68
[46] EFFICACY AND SAFETY OF BARICITINIB IN PATIENTS WITH ACTIVE LUPUS NEPHRITIS: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED PHASE 3 TRIAL
Hassanien, M.
Moshrif, A.
Hetta, H.
ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 34 - 35
[47] Efficacy of brexpiprazole in patients with acute schizophrenia: Review of three randomized, double-blind, placebo-controlled studies
Correll, Christoph U.
Skuban, Aleksandar
Hobart, Mary
Ouyang, John
Weiller, Emmanuelle
Weiss, Catherine
Kane, John M.
SCHIZOPHRENIA RESEARCH, 2016, 174 (1-3) : 82 - 92
[48] A Randomized, Double-blind, Active-and Placebo-controlled Phase 3 Study of Efficacy and Safety of Ixekizumab, Adalimumab, and Placebo Therapy in Patients Naive to Biologic Disease Modifying Antirheumatic Drugs with Active Psoriatic Arthritis
Mease, Philip
van der Heijde, Desiree
Ritchlin, Christopher
Cuchacovich, Raquel
Shuler, Catherine
Lin, Chen-Yen
Vangerow, Harald
Samanta, Suvajit
Lee, Chin
Gladman, Dafna
JOURNAL OF RHEUMATOLOGY, 2016, 43 (06) : 1169 - 1169
[49] Secukinumab in Active Rheumatoid Arthritis: A Phase III Randomized, Double-Blind, Active Comparator- and Placebo-Controlled Study
Blanco, Francisco J.
Moericke, Ruediger
Dokoupilova, Eva
Codding, Christine
Neal, Jeffrey
Andersson, Mats
Rohrer, Susanne
Richards, Hanno
ARTHRITIS & RHEUMATOLOGY, 2017, 69 (06) : 1144 - 1153
[50] EFFICACY OF DEUCRAVACITINIB, AN ORAL, SELECTIVE TYROSINE KINASE 2 INHIBITOR, IN MUSCULOSKELETAL MANIFESTATIONS OF ACTIVE PSORIATIC ARTHRITIS IN A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
Mease, P. J.
Deodhar, A.
Van der Heijde, D.
Behrens, F.
Kivitz, A.
Lehman, T.
Wei, L.
Nys, M.
Banerjee, S.
Nowak, M.
ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 137 - 138

← 1 2 3 4 5 →